September 10, 2010
Alan R. Goodman
Alan Goodman
Practice Areas Airplane Accidents Bad Drugs Bad Foods Boating Accidents Car Accidents Cerebral Palsy Construction Accidents Dangerous Products Dog Bites DUI / DRAM Medical Malpractice Medical Spas Motorcycle Accidents Nursing Home Abuse Personal Injury Law Pharmacy, Pharmacist, Filling Prescriptions Premises Liability Railroad Accidents Slip & Fall Accidents Social Security Law Spinal Cord Injury Traumatic Brain Injury Unintentional Poisoning Deaths from Medication Workers' Compensation Wrongful Death
Product Recalls and LitigationDrug Recalls and Litigation
Blog With Us
Phone 413-736-1616Quick Connect
FeaturesAmerican Association for JusticeNews You Can UseContact CongressOnline JuryLegal DictionaryInstructions for Injury ClientsHome Safety TipsFree Case Evaluation
More Content Useful Links Resources Food & Wine

Redux

Redux is a diet drug that was approved for use by the Federal Drug Administration in 1996 and withdrawn on Sept. 15, 1997, after heart valve damage was detected in patients using the drug. During its one year on the market, Redux generated sales of $ 255.3 million. There have been 123 deaths related to use of Redux.

Lawsuits now pending allege that Redux is linked to heart-valve disease and an often fatal lung condition known as Primary Pulmonary Hypertension (PPH). About 6,000 lawsuits to date have been filed on behalf of 11,000 plaintiffs who took the diet drug. There is evidence that the dangers of the drug were well known before it was removed from the market. In 1995, while the drug was in the approval stage, the lead FDA medical officer reviewing Redux believed the drug had low effectiveness and very high risk for neurotoxicity and pulmonary hypertension.

The lawsuits also allege that the company failed to adequately disclose the risks of these conditions. American Home Products, the manufacturer of Redux, has contended it acted responsibly. In the wake of increasing litigation, however, American Home Products has agreed to pay or set aside $ 3.75 billion to settle lawsuits related to the drugs' potential to cause heart valve damage for the next 15 years. According to a Boston University School of Medicine study, almost 2 million former users have heart valve damage. So far, fewer than 500,000 users have received compensation from lawsuits. Click on Redux/Pondimin Settlement Agreement, to see the terms of the national settlement.

If you or a loved one is in need of legal assistance, call The Law Offices of Alan R. Goodman at 1-413-736-1616 or submit an online questionnaire. The initial consultation is free of charge, and if we agree to handle your case, we will work on a contingency fee basis, which means we get paid for our services only if there is a monetary recovery of funds. In many cases, a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. Please call right away to ensure that you do not waive your right to possible compensation.



More Information

Phen-Fen Pondimin Redux / Pondimin Settlement Agreement Phen-Fen Heart Valve Disease

Resources

Heart Info RxList PPH Newsletter

Disclainer: Attorney Goodman is licensed to practice law in Massachusetts only but does appear in Federal Courts throughout the country on motion and through local counsel; most cases outside Massachusetts are referred to affiliates; past results is no guarantee of future results; legal information offered here is for informational purposes only and does not constitute formal legal advice; submission of a client inquiry is confidential but does not give rise to an attorney client relationship unless a formal fee agreement is signed by both parties.